Table 1 Number and percentage of patients by level of treatment at PTC by patient characteristics
Level of treatment at PTC | ||||||
|---|---|---|---|---|---|---|
All | Some | None | Not known | |||
Characteristic | Total | n (%) | n (%) | n (%) | n (%) | p-value |
Diagnostic group | ||||||
Leukaemia | 684 | 567 (82.9) | 63 (9.2) | 48 (7.0) | 6 (0.9) | <0.001 |
Lymphoma | 558 | 328 (58.8) | 92 (16.5) | 134 (24.0) | 4 (0.7) | |
CNS tumours | 547 | 478 (87.4) | 21 (3.8) | 36 (6.6) | 12 (2.2) | |
Germ cell tumours | 364 | 146 (40.1) | 134 (36.8) | 82 (22.5) | 2 (0.5) | |
Soft tissue sarcomas | 171 | 125 (73.1) | 29 (17.0) | 15 (8.8) | 2 (1.2) | |
Bone tumours | 163 | 136 (83.4) | 17 (10.4) | 3 (1.8) | 7 (4.3) | |
Age group | ||||||
0–4 years | 496 | 460 (92.7) | 22 (4.4) | 6 (1.2) | 8 (1.6) | <0.001 |
5–9 years | 371 | 355 (95.7) | 11 (3.0) | 2 (0.5) | 3 (0.8) | |
10–14 years | 405 | 371 (91.6) | 18 (4.4) | 11 (2.7) | 5 (1.2) | |
15–19 years | 559 | 329 (58.9) | 115 (20.6) | 105 (18.8) | 11 (2.0) | |
20–24 years | 655 | 265 (40.5) | 190 (29.0) | 194 (29.6) | 6 (0.9) | |
Sex | ||||||
Males | 1538 | 1055 (68.6) | 251 (16.3) | 208 (13.5) | 24 (1.6) | <0.001 |
Females | 949 | 725 (76.4) | 105 (11.1) | 110 (11.6) | 9 (0.9) | |
Diagnosis period | ||||||
1998–2005 | 1671 | 1168 (69.9) | 254 (15.2) | 226 (13.5) | 23 (1.4) | 0.07 |
2006–2009 | 816 | 612 (75.0) | 102 (12.5) | 92 (11.3) | 10 (1.2) | |
Total | 2487 | 1780 (71.6) | 356 (14.3) | 318 (12.8) | 33 (1.3) | |